NCT03755635

Brief Summary

Background: Neonatal sepsis is a major contributor to global under five mortality. In developing countries a major proportion of neonatal sepsis is thought to emanate from the healthcare setting, due to challenges in infection prevention practices. Aim: To study the epidemiology of neonatal sepsis and evaluate the effect of multimodal infection control interventions on the incidence of neonatal sepsis; and colonization by multidrug resistant Gram negative bacteria (MDRGNB). Methods: A controlled before and after interventional trial comprising a 7 month pre- intervention phase, 5 month intervention phase and 7 month post-intervention phase. Neonates admitted at the Neonatal Intensive Care Unit (NICU) at Korle-Bu Teaching Hospital (KBTH) will be enrolled prospectively and followed up for diagnosis of sepsis and outcome of admission. This will be used to describe the epidemiology of neonatal sepsis. Swabs will be collected from a subpopulation of included neonates at intervention site (KBTH) and control site (37 Military Hospital) NICUs to assess colonization of neonates with MDRGNB. Environmental swabs will be collected from surfaces at the NICU to assess MDRGNB contamination of the environment. The intervention comprises infection prevention strategies including implementation of the WHO multimodal hand hygiene strategy. The primary endpoint is incidence of neonatal sepsis. Expected Outcome: This study will contribute to improved infection prevention practices in the participating NICUs and highlight lessons which other national and regional NICUs may learn from.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,433

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 28, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
Last Updated

October 11, 2021

Status Verified

October 1, 2021

Enrollment Period

12 months

First QC Date

November 23, 2018

Last Update Submit

October 8, 2021

Conditions

Keywords

Neonatal sepsisInfection controlHand hygieneWHO multi modal

Outcome Measures

Primary Outcomes (1)

  • Incidence of neonatal sepsis

    Incidence of neonatal sepsis including clinical cases treated as sepsis and cases of neonatal sepsis with confirmed bloodstream infections per 1000 admissions.

    Post-intervention at 7 months

Secondary Outcomes (4)

  • Rate of hand hygiene compliance per opportunity

    Post-intervention at 7 months

  • Rate of MDR Gram negative bacteria colonization among neonates

    During intervention at 2 months and post-intervention at 7 months

  • Length of admission in days

    Post-intervention at 7 months

  • All-cause mortality

    Post-intervention at 7 months

Study Arms (2)

Standard of care

NO INTERVENTION

Continuously monitoring of neonatal sepsis under standard of care at one site

Hand hygiene

EXPERIMENTAL

The WHO multimodal hand hygiene strategy is implemented at one site

Combination Product: The WHO multimodal hand hygiene strategy

Interventions

Comprises five essential elements; system change-availability of alcohol-based hand rub at the point of care and/ or access to safe continuous water supply and soap and towels; training and education of healthcare professionals; monitoring of hand hygiene practices and performance feedback; reminders in the workplace; and the creation of a hand hygiene safety culture with the participation of both individual healthcare workers and senior hospital managers.

Also known as: Hand hygiene
Hand hygiene

Eligibility Criteria

Age1 Minute - 48 Hours
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Admission NICU
  • Birth weight ≥750 Grams
  • ≤48 hours of age at time of enrolment
  • Consent to participate obtained from legal guardian

You may not qualify if:

  • Neonates with severe congenital malformations
  • Neonates who have undergone surgical procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Korle Bu Teaching Hospital

Accra, Ghana

Location

Related Publications (1)

  • Labi AK, Enweronu-Laryea CC, Nartey ET, Bjerrum S, Ayibor PK, Andersen LP, Newman MJ, Kurtzhals JAL. Bloodstream Infections at Two Neonatal Intensive Care Units in Ghana: Multidrug Resistant Enterobacterales Undermine the Usefulness of Standard Antibiotic Regimes. Pediatr Infect Dis J. 2021 Dec 1;40(12):1115-1121. doi: 10.1097/INF.0000000000003284.

MeSH Terms

Conditions

Neonatal Sepsis

Interventions

Hand Hygiene

Condition Hierarchy (Ancestors)

SepsisInfectionsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

HygieneTherapeuticsPublic HealthEnvironment and Public Health

Study Officials

  • Appiah Korang Labi, MD

    Department of Int. Health and Immunlogy Microbiology, University og Copenhagen

    PRINCIPAL INVESTIGATOR
  • Jørgen Kurtzhals, Professor

    Department of Int. Health and Immunlogy Microbiology, University og Copenhagen

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Controlled before and after interventional trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, PHD, postdoc

Study Record Dates

First Submitted

November 23, 2018

First Posted

November 28, 2018

Study Start

October 1, 2018

Primary Completion

September 30, 2019

Study Completion

September 30, 2019

Last Updated

October 11, 2021

Record last verified: 2021-10

Locations